Literature DB >> 6092428

Anomalous antibody responses in viral infection: specific stimulation or polyclonal activation?

N E Cremer, V L Devlin, J L Riggs, S J Hagens.   

Abstract

Eighteen paired serum samples submitted for serodiagnosis of current infection showed anomalous antibody results by complement fixation test when tested with a battery of agents (viruses, Mycoplasma pneumoniae, and chlamydia) selected for testing on the basis of the symptoms of the patient. Seventeen serum pairs showed a fourfold or greater rise in titer of antibody to two agents in the battery, and one showed only a twofold rise in titer of antibody to the identified causative agent but an eightfold rise in titer of antibody to a heterologous agent. The 18 serum pairs were tested for IgM antibody to the two involved agents to determine whether IgM antibody tests would better distinguish the probable cause of the current infection. The serum pairs were separated into three groups based on their IgM responses. Group I consisted of six serum pairs with IgM antibody to both agents, four pairs of which showed a fourfold or greater rise in titer of IgM antibody to both agents, and two of which showed a rise in titer of IgM antibody to only one of the two agents. Group II consisted of 10 serum pairs with IgM antibody to one of the two agents, 7 pairs of which showed a fourfold or greater rise in titer of IgM antibody to the agent. Group III consisted of two serum pairs with no IgM antibody to either agent. Results show that determination of presence or absence of IgM antibody per se or demonstration of a fourfold or greater rise in specific IgM antibody titer does not always help in distinguishing the causative agent in current infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092428      PMCID: PMC271352          DOI: 10.1128/jcm.20.3.468-472.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Mycoplasma pneumoniae is a polyclonal B-cell activator.

Authors:  G Biberfeld; E Gronowicz
Journal:  Nature       Date:  1976-05-20       Impact factor: 49.962

2.  Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.

Authors:  P A Brunell; A A Gershon; S A Uduman; S Steinberg
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

3.  Neutralizing serum IgM antibodies in infections with Herpes simplex virus hominis.

Authors:  H W Doerr; G Gross; H Schmitz
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

4.  Cytomegalovirus macroglobulin in cell-associated herpesvirus infections.

Authors:  J B Hanshaw; J C Niederman; L N Chessin
Journal:  J Infect Dis       Date:  1972-03       Impact factor: 5.226

5.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Raised antibody titres to measles and rubella viruses in chronic active hepatitis.

Authors:  D R Triger; F O MacCallum; J B Kurtz; R Wright
Journal:  Lancet       Date:  1972-03-25       Impact factor: 79.321

Review 7.  Effect of virus infections on the function of the immune system.

Authors:  A L Notkins; S E Mergenhagen; R J Howard
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

8.  Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.

Authors:  K O Kalimo; R J Marttila; K Granfors; M K Viljanen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

9.  IgM antibodies to cytomegalovirus during pregnancy.

Authors:  D Kampa; H Schmitz; H W Doerr; T Luthardt; H G Hillemanns; A Wurtele
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

10.  Cytomegalovirus antibody production in renal transplant patients.

Authors:  J Nagington
Journal:  J Hyg (Lond)       Date:  1971-12
View more
  5 in total

1.  Fluctuation of virus antibody levels in healthy adults.

Authors:  O Meurman; O P Lehtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

Review 2.  Interactions of viruses with the immune system.

Authors:  C A Mims
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

3.  Coxsackievirus B1-based antibody-capture enzyme-linked immunosorbent assay for detection of immunoglobulin G (IgG), IgM, and IgA with broad specificity for enteroviruses.

Authors:  C M Swanink; L Veenstra; Y A Poort; J A Kaan; J M Galama
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

4.  Reactivation of Q fever following cardiac surgery.

Authors:  T J Marrie; J Cunning; P Durnford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

5.  Seroepidemiology of Q fever in Nova Scotia: evidence for age dependent cohorts and geographical distribution.

Authors:  T J Marrie; P T Pollak
Journal:  Eur J Epidemiol       Date:  1995-02       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.